Physician profile
Eric S Pulsfus
NPI 1053377150
$1,828.04
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $434 · 2020: $58.32 · 2021: $374 · 2022: $642 · 2023: $214 · 2024: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $543.22 | 2022-2024 | Xeomin |
| Abbvie INC. | $353.38 | 2019-2022 | |
| Coopersurgical, INC. | $111.61 | 2019-2022 | |
| Therapeuticsmd, INC. | $83.06 | 2019-2022 | |
| Caldera Medical, INC | $74.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.62 | 2019-2022 | |
| Exeltis, USA INC. | $55.67 | 2021-2022 | |
| Meditrina | $54.85 | 2021 | |
| Astellas Pharma US INC | $51.74 | 2019 | |
| Coloplast Corp | $49.26 | 2019-2022 | |
| Amgen INC. | $44.78 | 2019 | |
| Scynexis, INC. | $42.94 | 2022 | |
| Hologic Sales and Service, LLC | $41.51 | 2020-2022 | |
| Allergan, INC. | $40.79 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $36.91 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $29.05 | 2019-2022 | |
| Daiichi Sankyo INC. | $27.07 | 2019 | |
| Avion Pharmaceuticals | $24.52 | 2021-2022 | |
| Heron Therapeutics, INC. | $20.90 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.61 | 2019 | |
| Roche Diagnostics Corporation | $13.99 | 2019 | |
| Duchesnay USA Incorporated | $13.02 | 2019 | |
| Minerva Surgical, INC | $12.75 | 2021 | |
| Agile Therapeutics, INC. | $12.25 | 2022 | |
| Boston Scientific Corporation | $11.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pulsfus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.